Profile
Aaron L.
Cox is Chief Financial Officer & Executive Vice President at Lakefront Biotherapeutics since 2025.
Formerly, Mr. Cox was Chief Financial Officer & Executive Vice President at Horizon Therapeutics Ltd. (Ireland) from 2022 to 2023 and Vice President-Capital Markets at.
BMO Capital Markets Corp.
Education includes an undergraduate degree from the University of Notre Dame and an MBA from The University of Chicago Booth School of Business.
Aaron Cox active positions
| Companies | Position | Start |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Director of Finance/CFO | 2025-07-06 |
Former positions of Aaron Cox
| Companies | Position | End |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director of Finance/CFO | 2023-09-30 |
BMO Capital Markets Corp.
BMO Capital Markets Corp. Investment ManagersFinance BMOCMC serves as a sub-advisor to their affiliate BMO Asset Management, Inc. (BMOAM) in connection with the portfolio of the BMO US Equity Plus Fund. The fund seeks to provide long-term capital growth by investing primarily in equity securities of US and Canadian large-cap companies. The firm makes investment decisions based upon fundamental opinions and investment strategy quantitative analysis. | Corporate Officer/Principal | - |
Training of Aaron Cox
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
BMO Capital Markets Corp.
BMO Capital Markets Corp. Investment ManagersFinance BMOCMC serves as a sub-advisor to their affiliate BMO Asset Management, Inc. (BMOAM) in connection with the portfolio of the BMO US Equity Plus Fund. The fund seeks to provide long-term capital growth by investing primarily in equity securities of US and Canadian large-cap companies. The firm makes investment decisions based upon fundamental opinions and investment strategy quantitative analysis. | Finance |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Aaron Cox
















